Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Recent Patents on Anti-Cancer Drug Discovery Année : 2016

Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.

Résumé

This review, of the literature published between 2010 and 2015 reports that molecules containing a non-fused and/or fused pyrazole moiety could exhibit very potent activity toward Pim kinases, including the inhibition of cellular Bad phosphorylation as well as antiproliferative activity against various cancer cells. Even if Pim kinase inhibitors currently in clinical trial do not exhibit a pyrazole moiety, heteroaromatic kinase inhibitors containing an indazole part such as Axitinib and Pazopanib already reached the market. Therefore, one can imagine that in the future, heteroaromatic derivatives inhibiting Pim kinases including pyrazoles could be identified and used for their diagnostic and/or therapeutic potential alone or in combination with other drugs for the diseases in which Pim kinases are involved.
Fichier non déposé

Dates et versions

hal-01367766 , version 1 (16-09-2016)

Identifiants

Citer

Pascale Moreau, Fabrice Anizon, Francis Giraud, Yannick J Esvan. Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.. Recent Patents on Anti-Cancer Drug Discovery, 2016, 11, pp.309-321. ⟨10.2174/1574892811666160519141628⟩. ⟨hal-01367766⟩
87 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More